Rxsight Cash Conversion Cycle from 2010 to 2024

RXST Stock  USD 46.88  0.48  1.03%   
Rxsight Cash Conversion Cycle yearly trend continues to be comparatively stable with very little volatility. Cash Conversion Cycle is likely to outpace its year average in 2024. From the period from 2010 to 2024, Rxsight Cash Conversion Cycle quarterly data regression had r-value of (0.79) and coefficient of variation of  33.95. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
223.24430128
Current Value
335.56
Quarterly Volatility
160.21733463
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
  
Check out the analysis of Rxsight Correlation against competitors.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Latest Rxsight's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Rxsight over the last few years. It is Rxsight's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

Rxsight Cash Conversion Cycle Regression Statistics

Arithmetic Mean471.94
Geometric Mean439.45
Coefficient Of Variation33.95
Mean Deviation143.83
Median579.81
Standard Deviation160.22
Sample Variance25,670
Range373
R-Value(0.79)
Mean Square Error10,291
R-Squared0.63
Significance0.0004
Slope(28.38)
Total Sum of Squares359,374

Rxsight Cash Conversion Cycle History

2024 335.56
2023 223.24
2022 243.02
2021 206.63
2020 272.52

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle 223.24  335.56 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.